Cardiovascular Effectiveness of Sodium‐Glucose Cotransporter 2 Inhibitors and Glucagon‐Like Peptide‐1 Receptor Agonists in Older Patients in Routine Clinical Care With or Without History of Atherosclerotic Cardiovascular Diseases or Heart Failure

BACKGROUND: Randomized trials demonstrate the cardioprotective effects of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) and glucagon‐like peptide‐1 receptor agonists (GLP‐1RA). We evaluated their relative cardiovascular effectiveness in routine care populations with a broad spectrum of atherosc...

Descripción completa

Detalles Bibliográficos
Autores principales: Htoo, Phyo T., Buse, John, Cavender, Matthew, Wang, Tiansheng, Pate, Virginia, Edwards, Jess, Stürmer, Til
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245812/
https://www.ncbi.nlm.nih.gov/pubmed/35132865
http://dx.doi.org/10.1161/JAHA.121.022376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245812/
https://www.ncbi.nlm.nih.gov/pubmed/35132865
http://dx.doi.org/10.1161/JAHA.121.022376

Ejemplares similares